Wall Street analysts expect NCS Multistage Holdings Inc (NASDAQ:NCSM) to announce sales of $50.50 million for the current quarter, Zacks reports. Four analysts have issued estimates for NCS Multistage’s earnings, with the highest sales estimate coming in at $52.68 million and the lowest estimate coming in at $47.68 million. NCS Multistage reported sales of $50.18 million during the same quarter last year, which would suggest a positive year over year growth rate of 0.6%. The company is expected to announce its next earnings results on Thursday, March 14th.

According to Zacks, analysts expect that NCS Multistage will report full-year sales of $227.33 million for the current financial year, with estimates ranging from $224.45 million to $229.45 million. For the next financial year, analysts expect that the business will report sales of $245.44 million, with estimates ranging from $232.05 million to $262.82 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover NCS Multistage.

NCS Multistage (NASDAQ:NCSM) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The firm had revenue of $62.69 million during the quarter, compared to analyst estimates of $77.71 million. NCS Multistage had a net margin of 4.36% and a return on equity of 3.10%.

NCSM has been the topic of a number of analyst reports. Royal Bank of Canada reiterated a “buy” rating and issued a $19.00 price target on shares of NCS Multistage in a research report on Thursday, August 9th. BidaskClub upgraded shares of NCS Multistage from a “hold” rating to a “buy” rating in a report on Wednesday, August 1st. Piper Jaffray Companies set a $10.00 target price on shares of NCS Multistage and gave the stock a “buy” rating in a report on Thursday, November 8th. Credit Suisse Group set a $11.00 target price on shares of NCS Multistage and gave the stock a “buy” rating in a report on Monday, November 12th. Finally, TheStreet downgraded shares of NCS Multistage from a “c-” rating to a “d+” rating in a report on Thursday, November 1st. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $16.29.

Shares of NASDAQ:NCSM traded down $0.01 during mid-day trading on Tuesday, reaching $7.59. The stock had a trading volume of 355,900 shares, compared to its average volume of 157,196. The company has a market capitalization of $319.58 million, a price-to-earnings ratio of 37.95 and a beta of 2.14. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.89 and a quick ratio of 2.89. NCS Multistage has a twelve month low of $6.75 and a twelve month high of $20.54.

In related news, Director Michael Mcshane bought 30,000 shares of the company’s stock in a transaction on Tuesday, November 13th. The shares were purchased at an average cost of $7.36 per share, for a total transaction of $220,800.00. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Robert Nipper bought 62,955 shares of the company’s stock in a transaction on Friday, November 9th. The shares were bought at an average price of $7.55 per share, for a total transaction of $475,310.25. The disclosure for this purchase can be found here. Insiders have acquired a total of 122,113 shares of company stock worth $905,075 over the last 90 days. Corporate insiders own 11.70% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. FMR LLC grew its stake in shares of NCS Multistage by 18.1% during the 2nd quarter. FMR LLC now owns 4,311,228 shares of the company’s stock worth $62,642,000 after acquiring an additional 661,076 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of NCS Multistage by 17.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 49,765 shares of the company’s stock worth $723,000 after acquiring an additional 7,519 shares in the last quarter. BlackRock Inc. grew its stake in shares of NCS Multistage by 4.6% during the 2nd quarter. BlackRock Inc. now owns 513,917 shares of the company’s stock worth $7,468,000 after acquiring an additional 22,742 shares in the last quarter. Russell Investments Group Ltd. bought a new position in shares of NCS Multistage during the 2nd quarter worth approximately $4,939,000. Finally, JPMorgan Chase & Co. grew its stake in shares of NCS Multistage by 54.5% during the 1st quarter. JPMorgan Chase & Co. now owns 12,257 shares of the company’s stock worth $184,000 after acquiring an additional 4,322 shares in the last quarter. Hedge funds and other institutional investors own 95.94% of the company’s stock.

NCS Multistage Company Profile

NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.

Featured Story: What are no-load funds?

Get a free copy of the Zacks research report on NCS Multistage (NCSM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NCS Multistage (NASDAQ:NCSM)

Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.